HRMY logo

Harmony Biosciences Holdings, Inc. Common Stock

HRMY

HRMY: Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant), is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and used for the treatment of cataplexy in adult patients with narcolepsy.

more

Show HRMY Financials

Chart and Financial Data provided by TradingView

All
Government
Consumer Interest
SEC Filings
ESG/Other
Congress Trading

Recent trades of HRMY by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard
Whale Activity

Recently reported changes by institutional investors

Insider Trading

Quarterly net insider trading by HRMY's directors and management

Corporate Lobbying

Government lobbying spending instances

  • $250,000 Jul 19, 2023 Issue: Medicare/Medicaid Health Issues
  • $250,000 Apr 20, 2023 Issue: Medicare/Medicaid Health Issues
  • $250,000 Jan 20, 2023 Issue: Taxation/Internal Revenue Code Health Issues
  • $250,000 Oct 19, 2022 Issue: Health Issues
  • $250,000 Jul 20, 2022 Issue: Health Issues
  • $250,000 Apr 19, 2022 Issue: Health Issues
  • $250,000 Jan 19, 2022 Issue: Health Issues
  • $250,000 Oct 18, 2021 Issue: Health Issues
  • $250,000 Jul 19, 2021 Issue: Health Issues
  • $230,000 Apr 20, 2021 Issue: Health Issues
  • $140,000 Jan 20, 2021 Issue: Health Issues
  • $140,000 Oct 19, 2020 Issue: Health Issues
  • $140,000 Jul 20, 2020 Issue: Health Issues
  • $160,000 Apr 13, 2020 Issue: Health Issues
  • $160,000 Jan 20, 2020 Issue: Health Issues
  • $160,000 Oct 21, 2019 Issue: Health Issues
  • $160,000 Jul 16, 2019 Issue: Health Issues
  • $160,000 Apr 22, 2019 Issue: Health Issues
  • $80,000 Jan 20, 2019 Issue: Health Issues
  • $80,000 Oct 21, 2018 Issue: Health Issues
  • $30,000 Jul 19, 2018 Issue: Health Issues
U.S. Patents

New patents grants

  • Patent Title: Portable substance container with applicator Feb. 18, 2020
  • Patent Title: Portable container and method of manufacturing the same Mar. 06, 2018
Government Contracts

Federal grants, loans, and purchases

WallStreetBets

Number of mentions of HRMY in WallStreetBets Daily Discussion

HRMY News

Recent insights relating to HRMY

CNBC Recommendations

Recent picks made for HRMY stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in HRMY

Corporate Flights

Flights by private jets registered to HRMY